Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1981 3
1982 29
1983 18
1984 14
1985 29
1986 57
1987 71
1988 103
1989 121
1990 148
1991 134
1992 130
1993 142
1994 131
1995 104
1996 121
1997 117
1998 99
1999 91
2000 89
2001 86
2002 77
2003 94
2004 70
2005 73
2006 78
2007 76
2008 61
2009 80
2010 64
2011 60
2012 68
2013 77
2014 73
2015 79
2016 69
2017 50
2018 58
2019 60
2020 58
2021 44
Text availability
Article attribute
Article type
Publication date

Search Results

3,048 results
Results by year
Filters applied: . Clear all
Page 1
Buspirone in Children and Adolescents with Anxiety: A Review and Bayesian Analysis of Abandoned Randomized Controlled Trials.
Strawn JR, Mills JA, Cornwall GJ, Mossman SA, Varney ST, Keeshin BR, Croarkin PE. Strawn JR, et al. J Child Adolesc Psychopharmacol. 2018 Feb;28(1):2-9. doi: 10.1089/cap.2017.0060. Epub 2017 Aug 28. J Child Adolesc Psychopharmacol. 2018. PMID: 28846022 Free PMC article. Review.
Drop out as a result of a treatment-emergent adverse event was significantly greater in buspirone-treated patients compared to placebo (p = 0.011). Side effects were consistent with the known profile of buspirone with lightheadedness occurring more frequently in …
Drop out as a result of a treatment-emergent adverse event was significantly greater in buspirone-treated patients compared to placeb …
Azapirones for Attention Deficit Hyperactivity Disorder: A Systematic Review.
Matsui Y, Matsunaga S, Matsuda Y, Kishi T, Iwata N. Matsui Y, et al. Pharmacopsychiatry. 2016 May;49(3):97-106. doi: 10.1055/s-0042-102457. Epub 2016 Apr 13. Pharmacopsychiatry. 2016. PMID: 27074948 Review.
RESULTS: 5 RCTs (n=429) and 3 single-arm studies (n=70) were identified. 3 RCTs compared buspirone vs. methylphenidate in children/adolescents, one buspirone patches vs. placebo patches in children/adolescents, and one atomoxetine plus buspirone vs. atomoxeti …
RESULTS: 5 RCTs (n=429) and 3 single-arm studies (n=70) were identified. 3 RCTs compared buspirone vs. methylphenidate in children/ad …
Buspirone in clinical practice.
Rickels K. Rickels K. J Clin Psychiatry. 1990 Sep;51 Suppl:51-4. J Clin Psychiatry. 1990. PMID: 2211569 Review.
Buspirone, an azapirone derivative and a 5-HT1A partial agonist, is the first nonbenzodiazepine anxiolytic introduced into medicine for the treatment of generalized anxiety disorder. ...Slower and more gradual onset of anxiety relief is balanced by the increased safety and
Buspirone, an azapirone derivative and a 5-HT1A partial agonist, is the first nonbenzodiazepine anxiolytic introduced into medicine f
The effect of apatinib on pharmacokinetic profile of buspirone both in vivo and in vitro.
Zhang XD, Li YH, Chen DX, You WW, Hu XX, Chen BB, Hu GX, Qian JC. Zhang XD, et al. J Pharm Pharmacol. 2020 Oct;72(10):1405-1411. doi: 10.1111/jphp.13320. Epub 2020 Jun 30. J Pharm Pharmacol. 2020. PMID: 32608074
OBJECTIVE: In this study, we aimed to investigate the potential interaction of apatinib and buspirone and underlying mechanism. METHODS: UPLC-MS/MS assay was applied to determine the concentrations of buspirone and its main metabolites (1-PP and 6-OH buspirone
OBJECTIVE: In this study, we aimed to investigate the potential interaction of apatinib and buspirone and underlying mechanism. METHO …
Buspirone use for smoking cessation.
Farid P, Abate MA. Farid P, et al. Ann Pharmacother. 1998 Dec;32(12):1362-4. doi: 10.1345/aph.17175. Ann Pharmacother. 1998. PMID: 9876819 Review.
The results of buspirone efficacy have been inconsistent and contradictory. The rate of smoking abstinence has been reported to range from 36% to 88% and 16% to 89% in buspirone and placebo treatment groups, respectively. ...How buspirone compares with buprop …
The results of buspirone efficacy have been inconsistent and contradictory. The rate of smoking abstinence has been reported to range …
The Buspirone-dependent Abdominal Pain Transmission Within the Nucleus Tractus Solitarius in the Rat.
Panteleev SS, Sivachenko IB, Lyubashina OA. Panteleev SS, et al. Neuroscience. 2021 Jan 1;452:326-334. doi: 10.1016/j.neuroscience.2020.11.032. Epub 2020 Nov 26. Neuroscience. 2021. PMID: 33248152
Buspirone inhibits the responses of the excitatory neurons and inverts the responses of the inhibitory pain-related neurons but at a dose of 4.0 buspirone, the effect on NTS pain-related neurons attenuates. The inhibitory effect of buspirone on the CRD-evoked
Buspirone inhibits the responses of the excitatory neurons and inverts the responses of the inhibitory pain-related neurons but at a
Dopamine D3 receptors as a therapeutic target for methamphetamine dependence.
Paterson NE, Vocci F, Sevak RJ, Wagreich E, London ED. Paterson NE, et al. Am J Drug Alcohol Abuse. 2014 Jan;40(1):1-9. doi: 10.3109/00952990.2013.858723. Am J Drug Alcohol Abuse. 2014. PMID: 24359505 Review.
Pilot data (n = 5) indicated that buspirone is safe in MA-using individuals and comparison against historical placebo data from this laboratory suggested that at least some aspects of the subjective properties of MA may be diminished during buspirone treatment. CONC …
Pilot data (n = 5) indicated that buspirone is safe in MA-using individuals and comparison against historical placebo data from this …
[Buspirone: a new non-benzodiazepine anxiolytic drug].
Honorato J, Catalán M. Honorato J, et al. Rev Clin Esp. 1990 Apr;186(6):286-91. Rev Clin Esp. 1990. PMID: 2203117 Review. Spanish.
Its farmacokinetic characteristics make it a convenient drug to be used for oral administration. Buspirone's double-blind controlled clinical studies contrasted with benzodiazepines have shown that buspirone has an ansiolitic effect close to them but without …
Its farmacokinetic characteristics make it a convenient drug to be used for oral administration. Buspirone's double-blind cont …
Azaspirodecanediones in generalized anxiety disorder: buspirone.
Ortiz A, Pohl R, Gershon S. Ortiz A, et al. J Affect Disord. 1987 Sep-Oct;13(2):131-43. doi: 10.1016/0165-0327(87)90018-8. J Affect Disord. 1987. PMID: 2960708 Review.
Buspirone is a new anxiolytic that is structurally unrelated to other psychotropic drugs. ...Although buspirone's mechanism of action is unknown, it clearly does not act on the same receptor systems that are affected by benzodiazepines. ...
Buspirone is a new anxiolytic that is structurally unrelated to other psychotropic drugs. ...Although buspirone's mecha
3,048 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page